David S Alberts AZBio Pioneer
David S. Alberts, MD. Throughout his career, Dr. Alberts has focused on translational cancer prevention and treatment research. The emphasis of his laboratory-based and clinical research has been on the chemoprevention and treatment of such pervasive and potentially deadly diseases as cancers of the breast, colon, ovary, and skin. He has been the UA Cancer Center’s director since 2005. Under Dr. Alberts’ leadership the extensive research portfolio of The University of Arizona Cancer Center includes more than $60 million in annual research funding, including four large NCI interdisciplinary programs, and two Special Programs of Research Excellence, one in gastrointestinal cancers and one in lymphoma. Clinically, Dr. Alberts pioneered new treatments for advanced ovarian cancers, including in vitro tumor cell chemosensitivity testing for personalized medicine strategies, intraperitoneal chemotherapy , and maintenance chemotherapy. Presently, Dr. Alberts helps to coordinate Phase I and II and pharmacokinetic drug studies at The University of Arizona Cancer Center for molecularly-targeted chemopreventive agents. His laboratory research is concentrated on the evaluation of new surrogate endpoint biomarkers for cancer prevention trials with a special focus on precursor lesions for bladder, breast, colon, cervical, endometrial, ovarian, prostate, and skin cancers, using quantitative histopathology (i.e. karyometric) approaches. His NCI funded drug and diagnostics research has resulted in more than two dozen patents and the co-founding of five Arizona pharmaceutical and biotechnology companies.
A Global Perspective from executives of Arizona’s Bioscience Companies on why they are in Arizona Panelists Bob Bosserman, CEO, Medelis Janet Spear, Plant Manager, Celgene Joan Koerber-Walker, president & CEO, AZBio (moderator) Dr. Ken Wertman, Scientific Director, Sanofi, Oro Valley Dr. Phil Miller, Ventana Filmed live at the 2011 AZBio Expo
Linda Hunt of Dignity Health Arizona, 2013 Arizona Bioscience Leader of the Year
The Jon W. McGarity Arizona Bioscience Leader of the Year Award honors the person in Arizona who provided the most outstanding leadership that contributed significantly to development of the State’s bioindustry and/or recognition of the advancement of bioscience in Arizona. Recognizing that collaboration builds a stronger community, Linda Hunt has taken a leadership role to advance healthcare and the biosciences for the people of Arizona. Hunt has worked diligently with legislators, business leaders, educators, scientists and community organizations in order to identify, formulate, and support policies that will give Arizonans better healthcare and raise the bar of knowledge.Hunt has served as the head of Dignity Health in Arizona since 2012. Dignity Health includes three major hospitals in the Valley, St. Joseph’s Hospital and Medical Center and Chandler Regional and Mercy Gilbert Medical Centers. A fourth hospital, St. Joseph’s Westgate, is under construction.
Amanda Grimes 2013 Arizona Bioscience Educator of the Year
Some of the most important messages AZBio received about Mrs. Grimes work came from students she has helped to inspire: “She has taught each and every one of us that science can be fun too. A lot of people get stuck on the math but she opens it up to where it’s interesting and reels you in like a fish on a hook.” “As a high school graduate I can look back upon my time as a student and pick out a few teachers who have influenced my life and helped me flourish as a student. The number one teacher on that list is Mrs. Grimes. Having had Mrs. Grimes as a teacher for two years has helped me make connections, plan my future, and given me opportunities no other teachers have ever attempted. Without Mrs. Grimes I never would have joined the Biotech Academy at Mesa High School, meaning I would never have discovered my love for science and research.” “One of Mrs. Grimes’ most admirable qualities would be her patience with her students. Mrs. Grimes’ never ending patience and abundant respect for her students makes her an extraordinary teacher and mentor, always willing to answer questions or stay late to help. She does everything she can to ensure her students have every opportunity to advance their knowledge and experience beyond that of a typical high school student.” “Mrs. Grimes always encourages her students to excel in every aspect of their life, whether that be academics, community service, or extracurricular activities. I, and many of my peers, admire Mrs. Grimes for her dedication to her career and her students and wouldn’t be where we are if it weren't for her model of excellence.” “She has opened my eyes to the world of biotechnology and I am enthralled to be a part of it, I will not go quietly in this field.” The Biotechnology Academy (Mesa Public Schools) is a four-year program that provides freshmen-senior high students with experience in biotechnology theory and techniques, and prepares them for continuing education in Biotechnology Degree programs or related fields.
Leslie Boyer, MD 2013 Arizona Bioscience Researcher of the Year
In 2013, Dr. Leslie Boyer was been named one of 30 heroes of rare diseases by the Food and Drug Administration’s Office of Orphan Products Development. Her work includes a clinical studies program conducted throughout Arizona with protocols for placebo-controlled, double-blind trials, open-label studies, historical control studies, and the statewide STING project. She has coordinated phase 2 and phase 3 multicenter clinical trials of pit viper antivenom, developed the Antivenom Index, and participated in the establishment of the Pan-American Lymphotoxinology Taskforce. Boyer, who is a member of the UA’s BIO5 Institute, has focused her scientific career on venomous bites and stings, which are often unrecognized public health issues. She began by developing public education programs that offer poison and toxin emergency treatment advice. In 2004 and 2005, with an FDA Orphan Product grant, she led a team that conducted clinical studies leading to the marketing approval of the first scorpion antivenom – representing one of more than 40 products developed through orphan grant-sponsored research.
Arizona Commerce Authority05/17/2013
AZ Innovation Challenge Video
The Arizona Innovation Challenge (AIC), powered by the Arizona Commerce Authority , awards the most money in the country for a technology commercialization challenge – $3 million ($1.5 million twice yearly) to the world’s most promising technology ventures. Awards range from $100,000 to $250,000 per company. The results? A big-time investment in the most talented entrepreneurs. Bringing to market products that are literally changing the way the world works. Driving wealth and job creation for the state of Arizona. Are you up for the Challenge?